PolyPid Ltd. vs Regenxbio Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Regenxbio Inc. is the larger company by market value: $513 M against $103 M for PolyPid Ltd., 5.0 times as much (market caps of Aug 1, 2026 for PolyPid Ltd. and Oct 6, 2026 for Regenxbio Inc.). PolyPid Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- Both made a net loss: $34 M for PolyPid Ltd. and $194 M for Regenxbio Inc.
- Regenxbio Inc. employs more people: 372 against 59 at PolyPid Ltd.
Market value, the same start = 100
From Jan 2021: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | PolyPid Ltd. PYPD · #18,597 in the world | Regenxbio Inc. RGNX · #12,428 in the world |
|---|---|---|
| Profile | ||
| Country | 🇮🇱 Israel | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Market cap | $103 M | $513 M |
| Revenue | — | $170 M |
| Net income | $-34 M▲ best | $-194 M |
| Employees | 59 | 372 |
| Valuation | ||
| Price to sales | — | 3.3× |
| Price to book | 9.4× | 5.0× |
| Free cash flow yield | -27.2% | -24.6%▲ best |
| Profitability | ||
| Operating margin | — | -94.6% |
| Net margin | — | -113.8% |
| Return on equity | -366.4% | -107.0%▲ best |
| Growth | ||
| Revenue growth | — | 104.5% |
| Revenue growth, 3 years a year | — | 14.8% |
| Earnings per share growth | -57.4% | — |
| Cash | ||
| Free cash flow margin | — | -74.1% |
| Altman Z-score zone | — | distress |
| Data as of | Market cap Aug 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, PolyPid Ltd. or Regenxbio Inc.?
Regenxbio Inc. is the larger company by market value: $513 M against $103 M for PolyPid Ltd., 5.0 times as much (market caps of Aug 1, 2026 for PolyPid Ltd. and Oct 6, 2026 for Regenxbio Inc.). PolyPid Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, PolyPid Ltd. or Regenxbio Inc.?
Both made a net loss: $34 M for PolyPid Ltd. and $194 M for Regenxbio Inc.
Which has more employees, PolyPid Ltd. or Regenxbio Inc.?
Regenxbio Inc. employs more people: 372 against 59 at PolyPid Ltd.
More about PolyPid Ltd.
More about Regenxbio Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.